249 related articles for article (PubMed ID: 25975639)
1. The relationship between target-class and the physicochemical properties of antibacterial drugs.
Mugumbate G; Overington JP
Bioorg Med Chem; 2015 Aug; 23(16):5218-24. PubMed ID: 25975639
[TBL] [Abstract][Full Text] [Related]
2. Metabolite concentration as a criterion for antibacterial discovery.
Wang ZY; Zhu Q; Zhang HY
Curr Comput Aided Drug Des; 2013 Sep; 9(3):412-6. PubMed ID: 24010936
[TBL] [Abstract][Full Text] [Related]
3. AntiBac-Pred: A Web Application for Predicting Antibacterial Activity of Chemical Compounds.
Pogodin PV; Lagunin AA; Rudik AV; Druzhilovskiy DS; Filimonov DA; Poroikov VV
J Chem Inf Model; 2019 Nov; 59(11):4513-4518. PubMed ID: 31661960
[TBL] [Abstract][Full Text] [Related]
4. Bacterial histidine kinases as novel antibacterial drug targets.
Bem AE; Velikova N; Pellicer MT; Baarlen Pv; Marina A; Wells JM
ACS Chem Biol; 2015 Jan; 10(1):213-24. PubMed ID: 25436989
[TBL] [Abstract][Full Text] [Related]
5. Unconventional Antibacterials and Adjuvants.
Chang M; Mahasenan KV; Hermoso JA; Mobashery S
Acc Chem Res; 2021 Feb; 54(4):917-929. PubMed ID: 33512995
[TBL] [Abstract][Full Text] [Related]
6. (Dis)similar Analogues of Riboswitch Metabolites as Antibacterial Lead Compounds.
Matzner D; Mayer G
J Med Chem; 2015 Apr; 58(8):3275-86. PubMed ID: 25603286
[TBL] [Abstract][Full Text] [Related]
7. Origins of the Quinolone Class of Antibacterials: An Expanded "Discovery Story".
Bisacchi GS
J Med Chem; 2015 Jun; 58(12):4874-82. PubMed ID: 25738967
[TBL] [Abstract][Full Text] [Related]
8. Current Technology in the Discovery and Development of Novel Antibacterials.
Chung PY
Curr Drug Targets; 2018; 19(7):832-840. PubMed ID: 28891454
[TBL] [Abstract][Full Text] [Related]
9. Integrating bacterial molecular genetics with chemical biology for renewed antibacterial drug discovery.
Parkhill SL; Johnson EO
Biochem J; 2024 Jul; 481(13):839-864. PubMed ID: 38958473
[TBL] [Abstract][Full Text] [Related]
10. Combating multidrug-resistant bacteria: current strategies for the discovery of novel antibacterials.
O'Connell KM; Hodgkinson JT; Sore HF; Welch M; Salmond GP; Spring DR
Angew Chem Int Ed Engl; 2013 Oct; 52(41):10706-33. PubMed ID: 24038605
[TBL] [Abstract][Full Text] [Related]
11. Are the physicochemical properties of antibacterial compounds really different from other drugs?
Ebejer JP; Charlton MH; Finn PW
J Cheminform; 2016; 8():30. PubMed ID: 27274770
[TBL] [Abstract][Full Text] [Related]
12. Bacterial DNA replication enzymes as targets for antibacterial drug discovery.
Sanyal G; Doig P
Expert Opin Drug Discov; 2012 Apr; 7(4):327-39. PubMed ID: 22458504
[TBL] [Abstract][Full Text] [Related]
13. Drugs for bad bugs: confronting the challenges of antibacterial discovery.
Payne DJ; Gwynn MN; Holmes DJ; Pompliano DL
Nat Rev Drug Discov; 2007 Jan; 6(1):29-40. PubMed ID: 17159923
[TBL] [Abstract][Full Text] [Related]
14. Multi-targeting by monotherapeutic antibacterials.
Silver LL
Nat Rev Drug Discov; 2007 Jan; 6(1):41-55. PubMed ID: 17159922
[TBL] [Abstract][Full Text] [Related]
15. New strategies for antibacterial drug design: targeting non-multiplying latent bacteria.
Coates AR; Hu Y
Drugs R D; 2006; 7(3):133-51. PubMed ID: 16752940
[TBL] [Abstract][Full Text] [Related]
16. A class of selective antibacterials derived from a protein kinase inhibitor pharmacophore.
Miller JR; Dunham S; Mochalkin I; Banotai C; Bowman M; Buist S; Dunkle B; Hanna D; Harwood HJ; Huband MD; Karnovsky A; Kuhn M; Limberakis C; Liu JY; Mehrens S; Mueller WT; Narasimhan L; Ogden A; Ohren J; Prasad JV; Shelly JA; Skerlos L; Sulavik M; Thomas VH; VanderRoest S; Wang L; Wang Z; Whitton A; Zhu T; Stover CK
Proc Natl Acad Sci U S A; 2009 Feb; 106(6):1737-42. PubMed ID: 19164768
[TBL] [Abstract][Full Text] [Related]
17. Antisense RNA regulation and application in the development of novel antibiotics to combat multidrug resistant bacteria.
Ji Y; Lei T
Sci Prog; 2013; 96(Pt 1):43-60. PubMed ID: 23738437
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and In Silico Molecular Docking Studies on Substituted Piperic Acid Derivatives as Inhibitors of Bacterial DNA Gyrase.
Chopra B; Dhingra AK; Prasad DN; Bhardwaj S; Dubey S
Curr Comput Aided Drug Des; 2020; 16(3):281-294. PubMed ID: 31288729
[TBL] [Abstract][Full Text] [Related]
19. [The history of the development and changes of quinolone antibacterial agents].
Takahashi H; Hayakawa I; Akimoto T
Yakushigaku Zasshi; 2003; 38(2):161-79. PubMed ID: 15143768
[TBL] [Abstract][Full Text] [Related]
20. Advances and strategies in discovery of new antibacterials for combating metabolically resting bacteria.
Bald D; Koul A
Drug Discov Today; 2013 Mar; 18(5-6):250-5. PubMed ID: 23032727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
